Skip to content
healthcare.dev

Sinus and Cold D

NDC 51316-339, Naproxen sodium, Pseudoephedrine hydrochloride, tablet, film coated, extended release, from CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED.

Product NDC
51316-339
Status
Listed
Labeler
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076518
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51316-339 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51316-339-015131603390120 BLISTER PACK in 1 CARTON (51316-339-01) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51316-339 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51316-339 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51316-339. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.